Press releases
Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors
Press release, Thursday, 23 January 2025
Nadine Balkanyi-Nordmann, an experienced legal, compliance and governance expert, will be recommended for election as a member of the Board of Directors at the next Annual General Meeting of the Galenica Group.
Galenica reports strong sales growth once again
Ad hoc announcement pursuant to Art. 53 LR, Thursday, 23 January 2025
Galenica Group sales once again performed very positively in 2024, with growth of 4.7% to CHF 3,922 million. As a result, Galenica outperformed the entire pharmaceutical market in terms of growth (+3.5%, IQVIA, Pharmaceutical Market Switzerland, YTD December 2024).
Galenica increases sales growth in the third quarter
Ad hoc announcement pursuant to Art. 53 LR, Thursday, 24 October 2024
Following solid sales growth of 2.6% in the first half of 2024, Galenica grew more strongly again in the third quarter and generated net sales of CHF 2,864.8 million to the end of September 2024. With growth of 4.1%, Galenica outperformed the growth of the overall pharmaceutical market (+2.9%, IQVIA, pharmaceutical market Switzerland, YTD September 2024).